1. Home
  2. SGMT vs AMTD Comparison

SGMT vs AMTD Comparison

Compare SGMT & AMTD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGMT
  • AMTD
  • Stock Information
  • Founded
  • SGMT 2006
  • AMTD 2003
  • Country
  • SGMT United States
  • AMTD France
  • Employees
  • SGMT N/A
  • AMTD N/A
  • Industry
  • SGMT
  • AMTD
  • Sector
  • SGMT
  • AMTD
  • Exchange
  • SGMT Nasdaq
  • AMTD Nasdaq
  • Market Cap
  • SGMT 93.7M
  • AMTD 78.6M
  • IPO Year
  • SGMT 2023
  • AMTD 2019
  • Fundamental
  • Price
  • SGMT $5.18
  • AMTD $1.15
  • Analyst Decision
  • SGMT Strong Buy
  • AMTD
  • Analyst Count
  • SGMT 5
  • AMTD 0
  • Target Price
  • SGMT $21.60
  • AMTD N/A
  • AVG Volume (30 Days)
  • SGMT 772.8K
  • AMTD 22.7K
  • Earning Date
  • SGMT 11-13-2024
  • AMTD 12-30-2024
  • Dividend Yield
  • SGMT N/A
  • AMTD N/A
  • EPS Growth
  • SGMT N/A
  • AMTD N/A
  • EPS
  • SGMT N/A
  • AMTD 2.37
  • Revenue
  • SGMT $2,000,000.00
  • AMTD $122,715,000.00
  • Revenue This Year
  • SGMT N/A
  • AMTD N/A
  • Revenue Next Year
  • SGMT N/A
  • AMTD N/A
  • P/E Ratio
  • SGMT N/A
  • AMTD $0.50
  • Revenue Growth
  • SGMT N/A
  • AMTD N/A
  • 52 Week Low
  • SGMT $2.25
  • AMTD $1.13
  • 52 Week High
  • SGMT $20.71
  • AMTD $2.43
  • Technical
  • Relative Strength Index (RSI)
  • SGMT 47.83
  • AMTD 34.22
  • Support Level
  • SGMT $5.61
  • AMTD $1.30
  • Resistance Level
  • SGMT $6.40
  • AMTD $1.33
  • Average True Range (ATR)
  • SGMT 0.52
  • AMTD 0.05
  • MACD
  • SGMT -0.10
  • AMTD -0.01
  • Stochastic Oscillator
  • SGMT 17.57
  • AMTD 5.85

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company focused on developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. The company's lead drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH).

About AMTD AMTD IDEA Group each representing six (6)

AMTD IDEA Group is a financial institution operating in five business segments: The capital market solutions segment assists customers in raising funds through equity and debt financing, private placements, and debt issuances. The digital solutions and other services segment provides institutional and corporate clients with paid access to enhance investor communication and relations, corporate communication also provides digital financial solution services. The Media and entertainment segment offers print and digital advertising campaigns, licensing, and marketing services including branded content, video production. The hotel operations, hospitality, and VIP services segment engages in hotel investments, hotel operations, hospitality, and VIP services; and Strategic investment segment.

Share on Social Networks: